Trinity Biotech (TRIB) received notice from Nasdaq that the company is not in compliance with Nasdaq Listing Rule 5450, requiring that listed securities maintain a minimum bid price of $1.00 per share, based on the closing bid price of the company’s American Depositary Shares for the last 30 consecutive business days.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRIB:
- Trinity Biotech’s Premier Hb9210 Wins Sole IFCC Gold HbA1c Classification for 2026
- Trinity secures regulatory approval for upstream manufacturing activities
- Trinity achieves IFCC Gold Classification for Premier Hb9210 HbA1c Analyser
- Trinity Biotech files to sell 55.89M American depositary shares
- Trinity Biotech Restructures Perceptive Debt With New $5 Million Term Loan and Expanded ADS Conversion Rights